Abstract
Introduction
The precise incidence of hydrocephalus in patients with mucopolysaccharidoses (MPS) is hard to determine, because the condition lacks a formal, consensus-based definition. The diagnosis of hydrocephalus depends on symptom profile, presence of neuroimaging features, and the outcome of diagnostic tests. Although numerous techniques are used to identify MPS patients who are most likely to have hydrocephalus and respond to treatment, no definitive method exists to prove diagnosis.
Purpose
The authors propose an algorithm to aid in the diagnosis and management of hydrocephalus in MPS patients.
Conclusions
The theory of venous hypertension associated with the morphological changes in the skull base and craniocervical junction indicate the need for future neuroimaging studies including cerebrospinal fluid (CSF) and venous flow measurements to monitor hydrocephalus progression and select therapeutic interventions in MPS patients. Preoperative planning should also be based on the increased risk of intraoperative and postoperative hemorrhagic complications.
Similar content being viewed by others
Abbreviations
- MPS:
-
Mucopolysaccharidoses
- CSF:
-
Cerebrospinal fluid
- GAGs:
-
Glycosaminoglycans
- MRI:
-
Magnetic resonance imaging
- VPS:
-
Ventriculoperitoneal shunting
- ICP:
-
Intracranial pressure
- INPH:
-
Idiopathic normal pressure hydrocephalus
- ETV:
-
Endoscopic third ventriculostomy
References
Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver C, Beudet A, Sly W, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3421–3452
Shinnar S, Singer HS, Valle D (1982) Acute hydrocephalus in Hurler’s syndrome. Am J Dis Child 136:556–557
Scarpa M, Almássy Z, Beck M, Bodamer O, Bruce IA, De Meirleir L, Guffon N, Guillén-Navarro E, Hensman P, Jones S, Kamin W, Kampmann C, Lampe C, Lavery CA, Teles EL, Link B, Lund AM, Malm G, Pitz S, Rothera M, Stewart C, Tylki-Szymanska A, van der Ploeg A, Walker R, Zeman J, Wraith JE (2011) Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis 6:72
Robertson SP, Klug GL, Rogers JG (1998) Cerebrospinal fluid shunts in the management of behavioural problems in Sanfilippo syndrome (MPS III). Eur J Pediatr 157(8):653–655
Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome: case report and review of the literature. Pediatr Neurosurg 35(1):35–38
Hoyme HE, Jones KL, Higginbottom MC, O’Brien JS (1981) Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. J Med Genet 18(3):237–239
Vedolin L, Schwartz IVD, Komlos M, Schuch A, Puga AC, Pinto LLC, Pires AP, Giugliani R (2007) Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. Am J Neuroradiol 28(6):1029–1033
Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM (1993) The mucopolysaccharidoses: characterization by cranial MR imaging. Am J Neuroradiol 14(6):1285–1292
Lachman R, Martin KW, Castro S, Basto MA, Adams A, Teles EL (2010) Radiologic and neuroradiologic findings in the mucopolysaccharidoses. J Pediatr Rehabil Med 3(2):109–118
Manara R, Priante E, Grimaldi M, Santoro L, Astarita L, Barone R, Concolino D, Di Rocco M, Donati MA, Fecarotta S, Ficcadenti A, Fiumara A, Furlan F, Giovannini I, Lilliu F, Mardari R, Polonara G, Procopio E, Rampazzo A, Rossi A, Sanna G, Parini R, Scarpa M (2011) Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis 34(3):763–780
Watts RW, Spellacy E, Kendall BE, du BG, Gibbs DA (1981) Computed tomography studies on patients with mucopolysaccharidoses. Neuroradiology 21(1):9–23
Vanneste JAL, Augustijn P, Dirven C, Tan WF, Goedhart ZD (1992) Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology 42(1):54–59
Gleason PL, Black PM, Matsumae M (1993) The neurobiology of normal pressure hydrocephalus. Neurosurg Clin N Am 4(4):667–675
Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD (2008) Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 5:10
Brinker T, Stopa E, Morrison J, Klinge P (2014) A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11:10
Rekate HL (2008) The definition and classification of hydrocephalus: a personal recommendation to stimulate debate. Cerebrospinal Fluid Res 5:2
Fowler GW, Sukoff M, Hamilton A, Williams JP (1975) Communicating hydrocephalus in children with genetic inborn errors of metabolism. Childs Brain 1(4):251–254
Silva Neto AR, Holanda GBM, Farias MCS, Costa GS, Pereira HSG (2013) Hydrocephalus in mucopolysaccharidosis type VI successfully treated with endoscopic third ventriculostomy. J Neurosurg Pediatr 11(3):327–330
Dalla-Corte A, Souza CFM, Vairo F, Vedolin LM, Longo MG, Anés M, Maeda FK, Federhen A, Rosa AT, Giugliania R (2017) An algorithm to assess the need for CSF shunting in mucopolysaccharidosis patients. Mol Genet Metab 120(1):S39
Souza CFM, DallaCorte A, Vairo F, Anés M, Vedolin LM, Ferreira MM, Aguzolli AAG, Perrone SGP, Federhen A, Giugliani R (2015) Diagnosing communicating hydrocephalus in mucopolysaccharidoses: correlation between cerebrospinal fluid flow imaging and lumbar pressure studies. Mol Genet Metab 114(2):S35–S36
Bosemani T, Orman G, Hergan B, Carson KA, Huisman TAGM, Poretti A (2014) Achondroplasia in children: correlation of ventriculomegaly, size of foramen magnum and jugular foramina, and emissary vein enlargement. Childs Nerv Syst 31(1):129–133
Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J (2004) Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46(8):666–672
Zafeiriou DI, Batzios SP (2013) Brain and spinal MR imaging findings in mucopolysaccharidoses: a review. Am J Neuroradiol 34(1):5–13
Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Lund AM, Malm G, Van der Ploeg AT, Zeman J (2008) Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167(3):267–277
Beck M, Cole G (1984) Disc oedema in association with Hunter’s syndrome: ocular histopathological findings. Br J Ophthalmol 68(8):590–594
Collins ML, Traboulsi EI, Maumenee IH (1990) Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. Ophthalmology 97(11):1445–1449
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124(6):e1228–e1239
Evans WA Jr (1942) An encepahlographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatr 47:931–937
Seto T, Kono K, Morimoto K, Inoue Y, Shintaku H, Hattori H, Matsuoka O, Yamano T, Tanaka A (2001) Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 50(1):79–92
Virhammar J, Laurell K, Cesarini KG, Larsson E-M (2014) The callosal angle measured on MRI as a predictor of outcome in idiopathic normal-pressure hydrocephalus. J Neurosurg 120(1):178–184
Ishii K, Kanda T, Harada A, Miyamoto N, Kawaguchi T, Shimada K, Ohkawa S, Uemura T, Yoshikawa T, Mori E (2008) Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur Radiol 18(11):2678–2683
Bradley WG (2000) Normal pressure hydrocephalus: new concepts on etiology and diagnosis. AJNR Am J Neuroradiol 21(40):1586–1590
Stoquart-ElSankari S, Lehmann P, Villette A, Czosnyka M, Meyer M-E, Deramond H, Balédent O (2009) A phase-contrast MRI study of physiologic cerebral venous flow. J Cereb Blood Flow Metab 29(6):1208–1215
Borlot F, Arantes PR, Quaio CR, da Silva Franco JF, Lourenço CM, Bertola DR, Kim CA (2014) New insights in mucopolysaccharidosis type VI: neurological perspective. Brain and Development 36(7):585–592
Zafeiriou DI, Savvopoulou-Augoustidou PA, Sewell A, Papadopoulou F, Badouraki M, Vargiami E, Gombakis NP, Katzos GS (2001) Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo’s syndrome B). Brain and Development 23(6):385–389
Aliabadi H, Reynolds R, Powers CJ, Grant G, Fuchs H, Kurtzberg J (2010) Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery 67(6):1476–1481
Avery RA (2014) Interpretation of lumbar puncture opening pressure measurements in children. J Neuro-Ophthalmology 34(3):284–287
Tolar J, Orchard PJ, Key NS, Blazar BR (2008) Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I. J Thromb Haemost 6(5):893–895
Aydin M, Akarsu S, Kabakus N, Akpolat N (2006) Mucopolysaccharidosis IIIB, cerebral vasculopathy and recurrent subdural hematoma. Indian Pediatr 43(5):437–440
Warf BC (2013) Congenital idiopathic hydrocephalus of infancy: the results of treatment by endoscopic third ventriculostomy with or without choroid plexus cauterization and suggestions for how it works. Childs Nerv Syst 29(6):935–940
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Dalla Corte, A., de Souza, C.F.M., Anés, M. et al. Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?. Childs Nerv Syst 33, 1073–1080 (2017). https://doi.org/10.1007/s00381-017-3476-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-017-3476-0